Entries by Dante Ferrarini

Xhale Assurance Issued U.S. Patent on Optimized Gas Supply using Photoplethysmography

GAINESVILLE, August 13, 2014 – Xhale, Inc. Xhale Assurance, Inc., developer of the Assurance Alar One-SenseTM pulse oximetry sensor, today announced issuance of US Patent US 8755857. This patent expands Assurance’s technology coverage of patient monitoring beyond pulse oximetry. Monitoring patient parameters on the nasal ala, a site fed by both the external and internal […]

Nauman Toor Joins Xhale, Inc.’s Board of Directors

GAINESVILLE, August 1, 2014 – Xhale, Inc. The Board of Directors of Xhale, Inc. today announced the appointment of Nauman (Nick) Toor as a board member of Xhale, Inc. Mr. Toor is a Co-Founder and the Chief Investment Officer of Luzich Partners, a multi-strategy investment fund with a focus on both public and private equity […]

Xhale’s SMART Technology Showcased at Drug Development, Medication Adherence, and Innovation Meetings

SMART® solution which enables the management of medication adherence and clinical trial outcomes highlighted at ASCP Annual Meeting, International HIV Adherence Conference, and the Catalent Institute Innovation Symposium GAINESVILLE, FL June 10, 2014 – Xhale Smart, Inc. Xhale Smart, Inc., developer of the SMART® Medication Adherence System, today announced that the company has been invited […]

Xhale Assurance Receives ISO 13485 Certification

GAINESVILLE, FL – April 1, 2014 – Xhale Assurance, Inc. Xhale Assurance, Inc., developer of the Assurance® Alar One-Sense™ pulse oximetry sensor, today announced it has received ISO 13485 certification, an internationally recognized quality standard for the establishment of Quality Management Systems for manufacturers of medical devices. The scope of Xhale’s ISO 13485 certification covers […]

Assurance® Alar One-SenseTM Pulse Oximetry Sensor to be Presented in Two Clinical Abstracts and an Educational Session at Society for Technology in Anesthesiology Meeting

Research shows faster response time and the ability to identify abnormal breathing patterns GLASTONBURY, CT (January 17, 2014) – Xhale Assurance, Inc., developer of the unique Assurance® Alar One-SenseTM Pulse Oximetry Sensor, today announced that its new Alar One-SenseTM Sensor is being highlighted in two clinical research presentations and an educational session on “Cutting Edge […]

LionsGate Technologies and Xhale Assurance announce a codevelopment agreement to bring the Xhale Alar One-Sense™ Pulse Oximetry Sensor to Mobile Health

Bringing together two leading sensor technologies to offer accurate and accessible vital signs monitoring at a fraction of the cost of current market solutions. VANCOUVER, B.C., GLASTONBURY CT — LionsGate Technologies Inc. (LGTmedical) and Xhale Assurance Inc. today announce the signing of an agreement that will see the two companies co-develop a first-of-its-kind multi-parameter sensor […]

Xhale SMART Achieves Significant Milestone with ISO 13485 Certification

GAINESVILLE, FL December 2, 2013 – Xhale, Inc. Xhale SMART, Inc., a subsidiary of Xhale, Inc. which is marketing a breakthrough medication adherence monitoring system, today announced it has received ISO 13485 certification, an internationally recognized quality standard for medical devices. The ISO 13485 certification covers the design, development, production, sales and service of the […]

Assurance® Alar One-Sense™ Pulse Oximetry Sensor Highlighted in Three Clinical Presentations at American Society of Anesthesiologists Annual Meeting

A New Technology “Right Under Our Nose” – Highlights Benefits of Pulse Oximetry Monitoring at Ala and Identifies Unique Ability to Detect Respiratory Parameters from a Single Point of Contact Sensor. GLASTONBURY, CT (October 10, 2013) – Xhale Assurance, Inc., developer of the unique Assurance® Alar One-Sense™ Pulse Oximetry Sensor, today announced that its new […]

Assurance Biosense to Unveil Next-Generation Alar Sensor at the International Anesthesia Research Society Meeting

New Device Surmounts Shortcomings of Existing Fingertip Sensors GLASTONBURY, CT (May 1, 2013) – Assurance Biosense, a subsidiary of Xhale, Inc., today announced that it will unveil its next-generation Assurance® Alar Sensor at the International Anesthesia Research Society (IARS) meeting in San Diego May 4-7, 2013. The IARS meeting is attended by more than 1,000 […]

Assurance Biosense Receives FDA 510(k) Clearance to Market Alar Sensor

Unique Nasal Ala Pulse Oximetry Sensor Alar Sensing Promises High-Levels of Accuracy, Stability and Monitoring Reliability Sensor Compatible with Large, Existing Installed Base of Pulse Oximeters GLASTONBURY, CT — Assurance Biosense, Inc., a subsidiary of Xhale, Inc., today announced receipt from the U.S. Food and Drug Administration (FDA) of 510(k) clearance to market its Assurance® […]

Assurance Biosense Announces Key Addition to Executive Team – Jack Auer Joins as Vice President of Marketing

GLASTONBURY, CT — Assurance Biosense, Inc., a subsidiary of Xhale, Inc., announced today that Jack Auer has joined the executive team as Vice President of Marketing. Mr. Auer will lead the market launch and establishment of distribution channels for the Company’s planned Assurance® product line. Mr. Auer is a marketing and brand strategist with over […]

Xhale’s SMART Biotechnologies Poised to Provide Solutions for Costly Drug Development

GAINESVILLE, FL – February 21, 2013 – Xhale, Inc. The urgent need to increase the efficiency of clinical drug trails was highlighted last Fall in the Report to the President on Propelling Innovation in Drug Discovery, Development, and Evaluation, written by the President’s Council of Advisors on Science and Technology (PCAST). The report points to […]

Chief Science Officer of Xhale subsidiary SMART Biotechnologies, Inc. elected an NAI Charter Fellow

The Chief Science Officer of the Xhale, Inc. subsidiary SMART Biotechnologies, Donn M. Dennis, M.D., F.A.H.A., has been elected a Charter Fellow by the National Academy of Inventors. GAINESVILLE, FL – February 15, 2013 Xhale, Inc. announced today that the Chief Science Officer of their subsidiary, SMART Biotechnologies, Inc., has been elected by the National […]

Assurance Biosense Announces Two New Scientific Abstracts Presented at 2013 Society for Technology in Anesthesia Meeting

GLASTONBURY, CT – January 11, 2013 Study Received an Award for Best Research Assurance Biosense, Inc., a subsidiary of Xhale, Inc., announced today the presentation of two new clinical abstracts at the annual meeting of the Society for Technology in Anesthesia (STA) underway in Phoenix, AZ. One abstract, “Single Breath Detection During Spontaneous Ventilation Using […]